Posts tagged with ‘Nasdaq First North Premier’

  • Isofol Announces Publication of an Abstract for the 2017 ASCO Annual Meeting

    Isofol Medical AB (publ) announces publication of an abstract regarding failure rate of standard rescue after high-dose methotrexate in osteosarcoma…

    by
  • Pareto Securities has notified Isofol Medical AB that stabilisation measures regarding the Company’s shares have been taken

     In connection with the offering to acquire newly issued shares in Isofol and the listing on Nasdaq First North Premier…

    by
  • Isofol accepted for presentation of abstract at the 2017 ASCO annual meeting

    Isofol Medical AB (publ) announces that an abstract has been accepted to be presented at the American Society of Clinical…

    by
  • Pareto Securities has notified Isofol Medical AB (publ) that stabilisation measures regarding the Company’s shares have been taken

    In connection with the offering to acquire newly issued shares in Isofol and the listing on Nasdaq First North Premier…

    by
  • Pareto Securities has notified Isofol Medical AB that stabilisation measures regarding the Company’s shares have been taken

    For a complete press release follow the link http://isofol.se/en/ipo/  For additional information, please contact: Anders Rabbe, Managing Director, Isofol Mob: +46 70…

    by
  • Isofol has successfully completed the ISO-MTX-003 study in which Modufolin® is evaluated as rescue therapy

    Isofol Medical AB announced today that the study ISO-MTX-003 evaluating Modufolin® as rescue therapy (after two cycles of HDMTX treatment)…

    by
  • Isofol’s largest shareholder and co-founder acquires shares in the company

    Isofol Medical AB (publ) announces today that its largest shareholder and co-founder, Bengt Gustavsson, now acquired circa 16 000 shares…

    by
  • Isofol’s Chairman of the Board acquires shares in the company

    Isofol Medical AB (publ) announces that its Chairman of the Board, Jan-Eric Österlund, now acquired 15,000 shares in Isofol to…

    by